These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17635379)

  • 21. Altered rectal perception in irritable bowel syndrome is associated with symptom severity.
    Posserud I; Syrous A; Lindström L; Tack J; Abrahamsson H; Simrén M
    Gastroenterology; 2007 Oct; 133(4):1113-23. PubMed ID: 17919487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucosal acid exposure sensitizes a subset of normal subjects to intra-oesophageal balloon distension.
    Peghini PL; Johnston BT; Leite LP; Castell DO
    Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):979-83. PubMed ID: 8930562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional heartburn: what it is and how to treat it.
    Fass R
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):23-33, v. PubMed ID: 19232278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: abdominal bloating and distension in functional gastrointestinal disorders--epidemiology and exploration of possible mechanisms.
    Agrawal A; Whorwell PJ
    Aliment Pharmacol Ther; 2008 Jan; 27(1):2-10. PubMed ID: 17931344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psychiatric aspects of the irritable bowel syndrome].
    Radziwiłłowicz P; Gil K
    Psychiatr Pol; 2007; 41(1):87-97. PubMed ID: 17494417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychiatric disorder, irritable bowel syndrome, and extra-intestinal symptoms in a population-based sample of twins.
    Lembo AJ; Zaman M; Krueger RF; Tomenson BM; Creed FH
    Am J Gastroenterol; 2009 Mar; 104(3):686-94. PubMed ID: 19223882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acid-related oesophageal sensitivity, not dysmotility, differentiates subgroups of patients with non-erosive reflux disease.
    Thoua NM; Khoo D; Kalantzis C; Emmanuel AV
    Aliment Pharmacol Ther; 2008 Mar; 27(5):396-403. PubMed ID: 18081729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why do subjects with irritable bowel syndrome seek health care for their symptoms?
    Ringström G; Abrahamsson H; Strid H; Simrén M
    Scand J Gastroenterol; 2007 Oct; 42(10):1194-203. PubMed ID: 17852851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired esophageal function in patients with irritable bowel syndrome.
    Bilić A; Jurcić D; Schwarz D; Marić N; Vcev A; Marusić M; Gabrić M; Spoljarić L
    Coll Antropol; 2008 Sep; 32(3):747-53. PubMed ID: 18982747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is visceral hypersensitivity correlated with symptom severity in children with functional gastrointestinal disorders?
    Castilloux J; Noble A; Faure C
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):272-8. PubMed ID: 18376243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission.
    Karling P; Danielsson A; Adolfsson R; Norrback KF
    Neurogastroenterol Motil; 2007 Nov; 19(11):896-904. PubMed ID: 17973640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gallstones, cholecystectomy and irritable bowel syndrome (IBS) MICOL population-based study.
    Corazziari E; Attili AF; Angeletti C; De Santis A
    Dig Liver Dis; 2008 Dec; 40(12):944-50. PubMed ID: 18406218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.
    Grigolon A; Cantù P; Savojardo D; Conte D; Penagini R
    J Clin Gastroenterol; 2008 Oct; 42(9):969-73. PubMed ID: 18719508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional heartburn vs. non-erosive reflux disease: similarities and differences.
    Hershcovici T; Zimmerman J
    Aliment Pharmacol Ther; 2008 Jun; 27(11):1103-9. PubMed ID: 18315589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bowel symptoms in nonerosive gastroesophageal reflux disease: nature, prevalence, and relation to acid reflux.
    Zimmerman J; Hershcovici T
    J Clin Gastroenterol; 2008 Mar; 42(3):261-5. PubMed ID: 18223499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity.
    Fitzgerald P; Cassidy Eugene M; Clarke G; Scully P; Barry S; Quigley Eamonn MM; Shanahan F; Cryan J; Dinan Timothy G
    Neurogastroenterol Motil; 2008 Dec; 20(12):1291-7. PubMed ID: 18823288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication.
    Broeders JA; Draaisma WA; Bredenoord AJ; de Vries DR; Rijnhart-de Jong HG; Smout AJ; Gooszen HG
    Br J Surg; 2009 Sep; 96(9):1023-30. PubMed ID: 19672931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of gastrointestinal symptoms in patients with chronic obstructive pulmonary disease.
    Niklasson A; Strid H; Simrén M; Engström CP; Björnsson E
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):335-41. PubMed ID: 18334878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.